We are live on ! Find out more
VNRX icon

VolitionRx Ltd
VNRX

47 hedge funds and large institutions have $22M invested in VolitionRx Ltd in 2020 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 15 increasing their positions, 14 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

7% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 14

0.02% more ownership

Funds ownership: 0.7% → 0.71% (+0.02%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

12% less capital invested

Capital invested by funds: $25M → $22M (-$3.01M)

15% less funds holding

Funds holding: 55 → 47 (-8)

64% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 11

Holders
47
Holders Change
-8
Holders Change %
-14.55%
% of All Funds
0.95%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
4
Increased
15
Reduced
14
Closed
11
Calls
$64K
Puts
–
Net Calls
+$64K
Net Calls Change
-$6K

Top Buyers

Rank Fund Capital Flow
1
Northern Trust
Northern Trust
Illinois
+$649K
2
LIM
Lagoda Investment Management
New York
+$644K
3
GCP
GSA Capital Partners
United Kingdom
+$385K
4
BlackRock
BlackRock
New York
+$275K
5
Morgan Stanley
Morgan Stanley
New York
+$116K

Top Sellers

Rank Fund Capital Flow
1
Two Sigma Investments
Two Sigma Investments
New York
-$175K
2
CPA
Cowen Prime Advisors
New York
-$155K
3
Jane Street
Jane Street
New York
-$128K
4
Renaissance Technologies
Renaissance Technologies
New York
-$112K
5
Squarepoint
Squarepoint
New York
-$99K

VNRX Hedge Fund Activity: Q3 2020 in Review

47 of the 4,970 institutional investors tracked by Wall St. Rank reported a position in VolitionRx Ltd (VNRX) for Q3 2020, worth a combined $22M — down 12% from $25M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of VNRX and 4 opened new positions — a net loss of 7 holders — while 14 trimmed existing stakes and 15 added.

The largest buyer was Northern Trust, adding an estimated $649K. The largest seller was Two Sigma Investments, exiting entirely with an estimated $175K sold.

  • 47 institutional investors held VolitionRx Ltd (VNRX) as of Q3 2020, down from 55 in Q2 2020.
  • Funds reported $22M of VolitionRx Ltd stock for Q3 2020, down 12% quarter-over-quarter.
  • 4 funds opened new VolitionRx Ltd positions in Q3 2020 and 11 closed out, a net change of -7 holders.
  • The largest VolitionRx Ltd buyer in Q3 2020 was Northern Trust, an estimated $649K added.
  • The largest VolitionRx Ltd seller in Q3 2020 was Two Sigma Investments, an estimated $175K sold.

Based on aggregated 13F filings for Q3 2020.